- Diagnosis
- History
- Examination
- Investigations
- History
- Management
- Interventions
Neurological History-Taking
Presenting Complaints
Headache
Onset, severity, location, aggravating / relieving, prodromal symptoms
Seizure
Witnessed, duration, LOC, collateral
Presyncope / Syncope
Lightheadedness / loss of consciousness
Visual Changes
Blurring, diplopia, amaurosis fugax
Olfactory Changes
Loss of olfactory sensation, altered olfaction
Hearing Changes
Tinnitus, hearing loss
Vertigo
Room spinning or patient spinning
Muscular Symptoms
Weakness, spasm, tremor, facial droop
Sensory Changes
Loss of sensation / tingling / burning
Neck Stiffness
Fevers, headache, photophobia
Dysarthria
Difficulty articulating
Onset, associated symptoms
Further History
Past Medical History
Cerebrovascular Events
TIA / stroke
How many, when, functional residual
Epilepsy
Frequency / last seizure, type of seizures
Migraines
Frequency, severity, symptoms, impact
Multiple Sclerosis
Family history, relapses, management
Parkinson's Disease
Symptoms, dopamine replacement regimen
Motor Neuron Disease
Clinical phenotype, manifestations, management, prognosis
Myaesthenia Gravis
Symptoms, past myaesthenic crisis
Cerebrovascular Risk Factors
IHD, AF, HTN, lipids, Diabetes
Medications
Social History
Substance History
Read More...
Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2007 Jun;61(6):504-13.Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. The Lancet Neurology. 2015 Mar 1;14(3):263-73.Dharmadasa T, Henderson RD, Talman PS, Macdonell RA, Mathers S, Schultz DW, Needham M, Zoing M, Vucic S, Kiernan MC. Motor neurone disease: progress and challenges. Medical Journal of Australia. 2017 May;206(8):357-62.Ferlisi M, Shorvon S. Seizure precipitants (triggering factors) in patients with epilepsy. Epilepsy & Behavior. 2014 Apr 1;33:101-5.Hajat C, Dundas R, Stewart JA, Lawrence E, Rudd AG, Howard R, Wolfe CD. Cerebrovascular Risk Factors and Stroke Subtypes: Differences Between Ethnic Groups. Stroke. 2001; 32: 37-42.Hayes MW, Fung VS, Kimber TE, O'Sullivan JD. Current concepts in the management of Parkinson disease. Medical Journal of Australia. 2010 Feb;192(3):144-9.Jankovic J. Parkinsons disease: clinical features and diagnosis. Journal of neurology, neurosurgery & psychiatry. 2008 Apr 1;79(4):368-76.Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. InSeminars in neurology 2004 Mar (Vol. 24, No. 01, pp. 75-81). Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA..Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine. 2004 Apr;29(4):484-505.Kennedy A, Zakaria R. Taking a Neurological History. Medicine. 2006; 36(10): 509-514.Lima, Marco A. What is the essential neurological examination?. Arquivos de neuro-psiquiatria. 2012 Dec; 70(12): 939.McDermott CJ, Shaw PJ. Diagnosis and management of motor neurone disease. Bmj. 2008 Mar 20;336(7645):658-62.Murthy JM, Meena AK, Chowdary GV, Naryanan JT. Myasthenic crisis: clinical features, complications and mortality. Neurology India. 2005 Jan 1;53(1):37.O'Brien MD. Taking a Neurological History. The Foundation Years. 2006; 2(1): 1-6.Palace J. Making the diagnosis of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 2001 Dec 1;71(suppl 2):ii3-8.Pearl PL. Neurological Problems of Jazz Legends. Journal of Child Neurology. 2009 Aug; 24(8): 1037-1042.Perlmutter JS. Assessment of Parkinson disease manifestations. Current protocols in neuroscience. 2009 Oct;49(1):10-.Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016 Jul 26;87(4):419-25.Shorvon SD. The etiologic classification of epilepsy. Epilepsia. 2011 Jun;52(6):1052-7.Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry. 2011 Oct 1;82(10):1132-41.Talbot K. Motor neurone disease. Postgraduate medical journal. 2002 Sep 1;78(923):513-9.